Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 53 for “"Lymphotoxin"”.
-
Notch1 and Lymphotoxin beta receptor in thymopoiesis
… by Aire. In this context, signaling through the lymphotoxin beta receptor (LTβR) was proposed to be upstream of Aire and both Aire-dependent and Aire-independent TSA expression. Here it is shown that LTβR deficient mice develop autoimmunity in a thymic stroma-dependent manner. Moreover, a …
-
Cellular Origin of Human Lymphotoxin and its Purification
… of human mononuclear cells to produce human lymphotoxin (LT) was examined. Peripheral blood mononuclear cells were seperated into OKT4+. OKT8+ and Leu-lla+ subpopulations by flow cytometry.
-
Arming ColoAd1 with tumor necrosis factor alpha and lymphotoxin alpha
… to assess the effects of expressing TNF and lymphotoxin <em>α</em> (LTA) locally in the tumour microenvironment, a syngeneic CT26 CRC model expressing soluble (sm), full length (fm) or membranebound (mbm) murine TNF or LTA under a doxycyclin-dependent promoter. Moreover, an oncolytic …
-
The Lymphotoxin/Type I IFN axis in CD8+ T cell responses
… examines the role of the TNF family member Lymphotoxin-α1β2 (LTαβ) and its cognate receptor Lymphotoxin-β receptor (LTβR) in modulating DC immunogenic functions that affect the cross-priming of CD8+ T cells against protein antigen in a help-dependent manner. In non-infection related immune …
-
ROLE OF LYMPHOTOXIN B RECEPTOR SIGNALING IN LYMPH NODE LYMPHANGIOGENESIS INDUCED BY IMMUNIZATION
… has not been identified. We hypothesize that lymphotoxin B receptor signaling mediated by B cells may drive this inflammation-induced lymphangiogenesis. Our findings reveal that indeed, inhibition of lymphotoxin B receptor signaling blocked lymph node swelling and lymphatic vessel network …
-
Cooperation between Retinoic Acid and Lymphotoxin Signals maintains Type 2 conventional dendritic cell homeostasis.
… previously shown the absence of DC-intrinsic lymphotoxin beta receptor (LTR) signaling results in a partial loss of cDC2 in the spleen. Using genetic and bone marrow chimera approaches, I determined that the previously described LTR-dependent cDC2 correspond to the cDC2a subset. However, …
-
The Role of Lymphotoxin-beta-Receptor Signaling in Dendritic Cell Function and T Cell Priming.
… of help-dependent CD8+ T cell responses. The lymphotoxin-beta receptor (LTβR) is another TNF family receptor on DC, and it’s ligands LTα1β2 and LIGHT are expressed on activated T cells. Since abrogated LTβR signaling impairs T cell immunity, we have examined whether LTαβ represents another …
-
Investigating the process and regulation of thymocyte egress by lymphotoxin beta receptor and thymic stroma
… important regulator of T-cell egress. Studies of lymphotoxin beta-receptor (LT\(\beta\)R) have revealed its critical role in T-cell egress as well as the development and function of lymph node mesenchyme. We hypothesized that (LT\(\beta\)R) regulation of thymic mesenchyme is critical forT-cell …
-
Type I Interferons-induced Follicular Translocation of Lymphotoxin-Expressing Marginal Zone B cells Initiates Lupus
… follicular translocation of membrane lymphotoxin (mLT)-expressing marginal zone (MZ) B cells in the spleen of lupus prone BXD2 mice. The mislocation of mLT+ MZ B cells induces two important pathogenic effects including deteriorations of marginal zone macrophages (MZMs) in the MZ, …
-
Charakterisierung eines neuen Tumor Nekrose Faktor (TNF) Rezeptor 2 (TNFR2) Agonisten: Der heteromere, membranständige Ligand Lymphotoxin α\(_2\)β
… der Tumor Nekrose Faktor-α (=TNF-α) sondern auch Lymphotoxin-α (=LTα) in Form von Trimeren an TNFR1 und TNFR2 binden kann. Durch diese Fähigkeit an beide Rezeptoren zu binden, haben diese zwei Liganden eine essentielle Rolle in der Entwicklung und dem Verlauf von Autoimmunerkrankungen. Bereits mit …
-
Modulation of T-cell responses to Murine Melanoma by Targeted-Cytokine Therapy.
… cytokines, i.e., interleukin 2 and lymphotoxin ɑ, if applied targeted to the tumor site. While interleukin 2 is boosting an already established T cell response and enables the recirculation of clonally expanded T cells, lymphotoxin ɑ's <i>modus operandi</i> is relying on newly …
Page 1 of 3